This approach was used to identify dysregulated pathways and prioritize candidate proteins for further investigation, ultimately leading us to focus on MTDH and SND1, two proteins known for their roles in metastasis and drug resistance in breast cancer13, which we investigated in the context of ovarian cancer. This evidence concerns the gene SND1 and ovarian carcinoma.